Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
Cardiac surgery is associated with a high risk of cardiovascular and other complications. The
investigators hypothesized that perioperative infusion of dexmedetomidine may reduce the
incidence of complications and mortality following cardiovascular surgery.